[Interleukin 6 in neutrophil cultures and mononuclear cells in blood serum of patients with Lyme disease].
The aim of this study was to estimate the release of IL-6 by human neutrophils (PMN) and peripheral blood mononuclear cells (PBMC) in patients with Lyme disease confronted with the serum levels. The cells were isolated from whole blood of 25 patients and of 10 healthy donors and cultured in the presence of LPS. In the culture supernatants and serum the concentration of IL-6 with ELISA (BioSource) were measured. In patients we observed higher values of IL-6 released by unstimulated PMN and PBMC in compared with control. In contrast to control, we didn't observe increased the release of IL-6 by LPS-stimulated PMN and PBMC as compared to unstimulated cells. In the serum of patient we found increased the concentration of IL-6. The higher ability of PMN and PBMC from patients with Lyme disease to release of IL-6 and the lack response to additional stimulation indicate the activation of PMN and PBMC in vivo.
Jabłońska
Ewa
E
Zakład Immunologii Akademii Medycznej w Białymstoku.
Puzewska
Wioletta
W
Marcińczyk
Magdalena
M
Hermanowska-Szpakowicz
Teresa
T
D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D007963:Leukocytes, Mononuclear / Q000378:metabolism*; D008193:Lyme Disease / Q000097:blood*; D008297:Male; D009504:Neutrophils / Q000378:metabolism*
D015850:Interleukin-6